|
Dolphin Intertrade Corp
11314 SW 135 CT. Miami, FL 33186 USA
Tel: (305)383-7600
URGENT SUPPLEMENT RECALL
May 20th, 2013
Contact:
Consumer:
Dolphin Intertrade Corp.
305-383-7600
Dear Valued Customer:
This is to inform you of a product recall involving
JaDera Weight Loss Supplement
Manufactured lot 10.06.2011
Expiration Date: 09.06.2013
This voluntary recall has
been initiated due to a sample analyzed by FDA and found to contain undeclared Sibutramine,
Sibutramine was a previously approved controlled substance for the
treatment of obesity that was removed from the U.S. market in October 2010
for safety reasons, making this product an unapproved new drug.
Products containing Sibutramine pose a
threat to consumers because Sibutramine is known to substantially increase
blood pressure and/or pulse rate in some patients and may present a
significant risk for patients with a history of coronary artery disease,
congestive heart failure, arrhythmias or stroke. These products may also
interact in life threatening ways with other medications a consumer may be
taking. The company has not received any reports of adverse events related
to this recall. The recall was initiated after discovering that
Sibutramine was included as an ingredient by the manufacturer.
JaDera Weight Loss Supplement is
marketed as a dietary supplement used as a weight loss aid and is packaged
in bottles of 30 capsules. The affected JaDera Weight Loss Supplement,
includes manufactured lot 10.06.2011 with Expiration Date: 09.06.2013.
JaDera Weight Loss Supplement was distributed Nationwide to consumers and
distributors. The products were distributed from February 2012 to May
2013.
Immediately examine your inventory and
quarantine product subject to the recall. In addition, if you may have
further distributed this product, please identify your consumers and
notify them at once of this product recall. Your notification to your
customers may enhanced by including a copy of this recall notification
letter. You may return the product to our postal address
Please complete and return the enclosed
response form as soon as possible. If you have any questions, call Mr.
Delfino at 305-383-7600.
This recall is being conducted with the
knowledge of the U.S. Food and Drug Administration.
|